The latest twist is the claim by Chinese police to have discovered an organised bribery ring within GSK's local office. The significance of that tale is that – if proved – it would be harder for the company to argue that it is the ...
GlaxoSmithKline plc (ADR) (GSK): China to release blacklist for corporate bribery Seeking Alpha Both GlaxoSmithKline (GSK +0.9%) and Danone SA (DANOY +1.5%) have been variously accused in China. Sent to 9,032 people ...
China's rapid economic development and the numerous steps of reform undertaken by the Chinese central government since 1997 have had clear and observable effects upon China's total healthcare services market and its product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a Reform program in 2009, which includes increased funding to improve services.
What are the workings of China's healthcare system? How much progress has been made towards the promised vision of the CPCC in 2008 to provide "convenient and affordable access" to its people? What are the effects on foreign companies seeking to benefit from an increase in healthcare-related funding? Where are the best opportunities in China for marketers? Kalorama analyst Emil Salazar focuses on these questions and more.
The report contains a comprehensive overview of the Chinese healthcare system with important data for marketers to China. It discusses healthcare reform plans and where funds were spent. It also describes the role foreign companies play. As part of its analysis, the report includes the following information:
Statistics on Chinese Hospitals, Community Health Centers and Clinics Top and Bottom City Markets for Urban Healthcare Top and Bottom Rural Regions Challenges for Foreign-Owned MNCs in China Government Healthcare Spending Foreign-Invested Manufacturing Enterprises in China Share of Government Funded Healthcare vs. Out of Pocket Domestic Healthcare Industries Population and Age Statistics Incidence Rates for Infectious Diseases Cancer Rates in China Regulation of Drugs and Devices in China U.S. Product Exports to China Key Analyst Conclusions
In addition to providing useful background information and a thorough analysis of China's healthcare changes, the report provides data for business planning. It also takes a look at the status and forecast of the three key healthcare markets in China:
The Chinese Market for IVD products Regional Breakout of the Chinese IVD Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern) The Chinese Market for Medical Device Products Regional Breakout of the Chinese Medical Device Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern) Segment Breakout of the Chinese Medical Device Market(Surgical Instrument, Disposable, Patient Monitoring, IVD, Imaging, Orthopedic, Other) The Chinese Market for Pharmaceutical Products Regional Breakout of the Pharmaceutical Market(Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern) Segment Breakout of the Pharmaceutical Market (Cardiovascular, Gastrointestinal, Anti-Infectives, Neurotherapeutics, Oncology, Respiratory, Other)
Table of Contents :
CHAPTER ONE: EXECUTIVE SUMMARY
Healthcare in China Healthcare Reform and Market Impact Rural Healthcare Market in Era of Reform Urban Healthcare Market in Era of Reform China’s IVD Market in an Era of Reform China’s Medical Devices Market in an Era of Reform China’s Pharmaceuticals Market in an Era of Reform Major Findings
CHAPTER TWO: HEALTHCARE IN CHINA - PRIMARY INDICATORS AND A NEED FOR REFORM
Introduction Barefoot Doctors and the Rural Cooperative Medical Scheme (RCMS) China’s Economic Reform Impacts Healthcare New Rural Cooperative Medical Scheme (NRCMS) and Government Recommitment to Reform China on the Eve of Contemporary Healthcare Reform
More Related Reports :
Cell Phone-Enabled Diagnostics: mHealth Applications in IVD
Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016
Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics
Markets for Electrostimulation Devices (Neurostimulation, Cardiac Rhythm Management, Fracture Healing and Others)
Medical Imaging Markets: Contrast Agents
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition
What's Next In Vaccines (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)
World Wound Care Markets (Skin Ulcer, Burns, Surgical/Trauma)
The World Market for Veterinary Diagnostics
The Market for Mobile Medical Apps
Consumer Testing and The Future of DTC Genetic Testing
The Global Market for Medical Devices, 3rd. Edition
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.